Vaccinex (VCNX) Presents At 2019 ASCO Annual Meeting - Slideshow

Pilot Integrated Biomarker Study of VX15/2503 in Combination with Ipilimumab and/or Nivolumab in Patients with Resectable Metastatic Melanoma Michael C. Lowe, MD1, Keith A. Delman MD1, Brian Olson, PhD2, Gregory B. Lesinski, MPH, PhD2, Melinda Yushak, MD2, Elizabeth E. Evans, PhD3, Desa Rae Pastore, MS 3, Maurice Zauderer, PhD3, Terrence L. Fisher, PhD3, Ragini R. Kudchadkar, MD2 1Division of Surgical Oncology, Department of Surgery, Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA ...